血液学指标联合细胞因子的脓毒症免疫麻痹 智能诊断模型构建
Construction of Intelligent Diagnostic Model for Sepsis-Induced Immunoparalysis Based on Combined Hematological Indicators and Cytokines
DOI: 10.12677/acm.2026.1672594, PDF,   
作者: 周婷婷:重庆医科大学检验医学院,重庆;余荣俊, 广玉洁, 张琼元, 薛建江, 吴茳铃*:重庆医科大学附属大学城医院检验科,重庆;谢 维:重庆医科大学附属大学城医院急诊科,重庆
关键词: 脓毒症免疫麻痹生物标志物智能诊断模型Sepsis Immune Paralysis Biomarkers Intelligent Diagnostic Models
摘要: 目的:联合血液学指标和细胞因子构建智能诊断模型,对脓毒症免疫麻痹进行早期识别与临床评估。方法:回顾性纳入了150例患者资料,包括健康对照组(25例)、普通炎症组(25例)、脓毒症非免疫麻痹组(50例)及脓毒症免疫麻痹组(50例)。收集所有患者的常规血液学指标、部分炎症和细胞因子指标,逐步进行指标筛选,最后把筛选出来的指标联合起来构建智能诊断模型,用受试者工作特征(Receiver Operating Characteristic, ROC)曲线评估各模型的诊断效能。结果:对患者数据进行筛选,最后选出核心预测指标为:白细胞计数(WBC)、C反应蛋白(CRP)、白细胞介素-1 (IL-1)、白细胞介素-4 (IL-4)。在以上指标的基础上构建智能诊断模型并进行十折交叉验证,结果显示决策树(Decision Tree)模型表现最佳,该模型在训练集与验证集间性能差距小,具有良好的泛化能力,提示决策树模型对脓毒症免疫麻痹具有优异的区分效能。结论:WBC、CRP、IL-1、IL-4是脓毒症免疫麻痹的高效识别标志物,决策树联合模型对其具有判别价值,有助于临床早期识别免疫麻痹状态与及时干预。
Abstract: Objective: To construct an intelligent diagnostic model by combining hematological indicators and cytokines for early identification and clinical evaluation of sepsis-induced immunoparalysis. Methods: A retrospective study was conducted including data from 150 patients, comprising a healthy control group (25 cases), a general inflammation group (25 cases), a sepsis non-immunoparalysis group (50 cases), and a sepsis immunoparalysis group (50 cases). Routine hematological indicators, along with selected inflammation and cytokine markers, were collected from all patients. Stepwise screening of indicators was performed, and the selected indicators were combined to build an intelligent diagnostic model. The diagnostic performance of each model was assessed using the receiver operating characteristic (ROC) curve. Results: Patient data were screened, and the core predictive indicators were ultimately selected as white blood cell count (WBC), C-reactive protein (CRP), interleukin-1 (IL-1), and interleukin-4 (IL-4). Based on these indicators, an intelligent diagnostic model was constructed and subjected to ten-fold cross-validation. The results showed that the Decision Tree model performed best, with a small performance gap between the training and validation sets, indicating good generalization ability. This suggests that the Decision Tree model has excellent discriminative power for sepsis-induced immunoparalysis. Conclusions: WBC, CRP, IL-1, and IL-4 are efficient markers for identifying immune paralysis in sepsis. The combined decision tree model shows good discriminative value, and this could help clinicians recognize immune paralysis early and intervene in time.
文章引用:周婷婷, 余荣俊, 广玉洁, 谢维, 张琼元, 薛建江, 吴茳铃. 血液学指标联合细胞因子的脓毒症免疫麻痹 智能诊断模型构建[J]. 临床医学进展, 2026, 16(7): 854-866. https://doi.org/10.12677/acm.2026.1672594

参考文献

[1] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 775-787. [Google Scholar] [CrossRef] [PubMed]
[2] Cohen, J., Vincent, J., Adhikari, N.K.J., Machado, F.R., Angus, D.C., Calandra, T., et al. (2015) Sepsis: A Roadmap for Future Research. The Lancet Infectious Diseases, 15, 581-614. [Google Scholar] [CrossRef] [PubMed]
[3] Venet, F. and Monneret, G. (2018) Advances in the Understanding and Treatment of Sepsis-Induced Immunosuppression. Nature Reviews Nephrology, 14, 121-137. [Google Scholar] [CrossRef] [PubMed]
[4] Hotchkiss, R.S., Monneret, G. and Payen, D. (2013) Sepsis-Induced Immunosuppression: From Cellular Dysfunctions to Immunotherapy. Nature Reviews Immunology, 13, 862-874. [Google Scholar] [CrossRef] [PubMed]
[5] 张盛, 唐吉斌, 鲁厚清, 等. 脓毒症患者外周血CD14+单核细胞HLA-DR、CD86和T淋巴细胞亚群表达水平的变化及其协同表达研究[J]. 国际检验医学杂志, 2021, 42(18): 2219-2221+2227.
[6] Rizzo, A.N. and Dudek, S.M. (2017) Endothelial Glycocalyx Repair: Building a Wall to Protect the Lung during Sepsis. American Journal of Respiratory Cell and Molecular Biology, 56, 687-688. [Google Scholar] [CrossRef] [PubMed]
[7] Joosten, S.C.M., Wiersinga, W.J. and Poll, T.v.d. (2024) Dysregulation of Host-Pathogen Interactions in Sepsis: Host-Related Factors. Seminars in Respiratory and Critical Care Medicine, 45, 469-478. [Google Scholar] [CrossRef] [PubMed]
[8] Steinhagen, F., Schmidt, S.V., Schewe, J., Peukert, K., Klinman, D.M. and Bode, C. (2020) Immunotherapy in Sepsis—Brake or Accelerate? Pharmacology & Therapeutics, 208, Article ID: 107476. [Google Scholar] [CrossRef] [PubMed]
[9] Monneret, G., Lepape, A., Voirin, N., Bohé, J., Venet, F., Debard, A., et al. (2006) Persisting Low Monocyte Human Leukocyte Antigen-DR Expression Predicts Mortality in Septic Shock. Intensive Care Medicine, 32, 1175-1183. [Google Scholar] [CrossRef] [PubMed]
[10] Döcke, W., Höflich, C., Davis, K.A., Röttgers, K., Meisel, C., Kiefer, P., et al. (2005) Monitoring Temporary Immunodepression by Flow Cytometric Measurement of Monocytic HLA-DR Expression: A Multicenter Standardized Study. Clinical Chemistry, 51, 2341-2347. [Google Scholar] [CrossRef] [PubMed]
[11] 齐霜, 徐浩然, 胡婕, 等. 基于机器学习的重症监护病房脓毒症患者早期死亡风险预测模型[J]. 解放军医学院学报, 2021, 42(2): 150-155+181.
[12] Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. (2013) Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Medicine, 39, 165-228. [Google Scholar] [CrossRef] [PubMed]
[13] 孙翰, 胡韡, 张楠, 等. 脓毒症相关炎症标志物急诊应用专家共识[J]. 临床急诊杂志, 2025, 26(5): 293-301.
[14] Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. [Google Scholar] [CrossRef] [PubMed]
[15] Giamarellos-Bourboulis, E.J., Kotsaki, A., Kotsamidi, I., Efthymiou, A., Koutsoukou, V., Ehler, J., et al. (2026) Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial. JAMA, 335, 775-786. [Google Scholar] [CrossRef
[16] 中国研究型医院学会休克与脓毒症专业委员会, 中国人民解放军重症医学专业委员会, 重症免疫研究协作组, 等. 脓毒症免疫抑制诊治专家共识[J]. 中华危重病急救医学, 2020, 32(11): 1281-1289.
[17] Badero, O.J., Omokore, O., Oore-ofe, O., Osibowale, B., Quadri, I., Olayinka, T., et al. (2026) Immune Endotype-Guided Precision Immunotherapy in Sepsis: From Transcriptomics to Bedside Application. Cureus, 18, e106312. [Google Scholar] [CrossRef
[18] Kox, M., Bauer, M., Bos, L.D.J., Bouma, H., Calandra, T., Calfee, C.S., et al. (2026) The Immunology of Sepsis: Translating New Insights into Clinical Practice. Nature Reviews Nephrology, 22, 30-49. [Google Scholar] [CrossRef
[19] Adami, M., Giamarellos-Bourboulis, E.J. and Polyzogopoulou, E. (2024) Towards Improved Point-of-Care (POC) Testing for Patients with Suspected Sepsis: POC Tests for Host Biomarkers and Possible Microbial Pathogens. Expert Review of Molecular Diagnostics, 24, 829-839. [Google Scholar] [CrossRef] [PubMed]
[20] Cajander, S., Kox, M., Scicluna, B.P., Weigand, M.A., Mora, R.A., Flohé, S.B., et al. (2024) Profiling the Dysregulated Immune Response in Sepsis: Overcoming Challenges to Achieve the Goal of Precision Medicine. The Lancet Respiratory Medicine, 12, 305-322. [Google Scholar] [CrossRef] [PubMed]
[21] Yang, Y., Zhang, Y., Wu, J., Liu, Y. and Lei, X. (2025) Decoding Immune Low-Response States in Sepsis: Single-Cell and 3D Spatial Transcriptomic Insights into Immunoparalysis. Frontiers in Immunology, 16, Article ID: 1696914. [Google Scholar] [CrossRef
[22] Lu, F., Chen, C., Feng, D., et al. (2025) Causal Relationships between Inflammatory Cytokines and Sepsis: A Mendelian Randomization Study. Annals of Clinical & Laboratory Science, 55, 64-71.
[23] You, W. (2025) Roles of Cytokine Storm in Sepsis Progression: Biomarkers, and Emerging Therapeutic Strategies. Frontiers in Immunology, 16, Article ID: 1696366. [Google Scholar] [CrossRef
[24] Gao, X., Cai, S., Li, X. and Wu, G. (2025) Sepsis-Induced Immunosuppression: Mechanisms, Biomarkers and Immunotherapy. Frontiers in Immunology, 16, Article ID: 1577105. [Google Scholar] [CrossRef] [PubMed]
[25] Santaolalla, A., Sollie, S., Rislan, A., Josephs, D.H., Hammar, N., Walldius, G., et al. (2021) Association between Serum Markers of the Humoral Immune System and Inflammation in the Swedish AMORIS Study. BMC Immunology, 22, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[26] Schrijver, D.P., Röring, R.J., Deckers, J., de Dreu, A., Toner, Y.C., Prevot, G., et al. (2023) Resolving Sepsis-Induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells. Nature Biomedical Engineering, 7, 1097-1112. [Google Scholar] [CrossRef] [PubMed]
[27] Zhu, G., Liao, Y., Liu, S., Liu, P., Yang, K., Tan, M., et al. (2025) Dysregulated Immune Responses in Sepsis: Insights from Treg-Related Gene Expression. Journal of Inflammation Research, 18, 11689-11702. [Google Scholar] [CrossRef
[28] West, S.D., Ziegler, A., Brooks, T., Krencicki, M., Myers, O. and Mold, C. (2015) An FcγRIIa Polymorphism with Decreased C-Reactive Protein Binding Is Associated with Sepsis and Decreased Monocyte HLA-DR Expression in Trauma Patients. Journal of Trauma and Acute Care Surgery, 79, 773-781. [Google Scholar] [CrossRef] [PubMed]
[29] Capitoli, G., Nobile, M.S., Ambags, E.L., L’Imperio, V., Provenzano, M. and Liò, P. (2025) Assisting Clinical Diagnosis with Interpretable Fuzzy Probabilistic Modelling. BMC Medical Informatics and Decision Making, 25, Article No. 330. [Google Scholar] [CrossRef
[30] Gao, W., Zhang, H., Fan, J., Wu, L. and Liu, W. (2026) LUCAT1/PTBP1/HIF-1α Feedback Loop Promotes T Cell Over-Differentiation and Th1/Th2-Skewed Immune Imbalance in Sepsis via Glucose Metabolism. Cytokine, 203, Article ID: 157157. [Google Scholar] [CrossRef
[31] Ho, V.P., Kaafarani, H., Rattan, R., Namias, N., Evans, H. and Zakrison, T.L. (2020) Sepsis 2019: What Surgeons Need to Know. Surgical Infections, 21, 195-204. [Google Scholar] [CrossRef] [PubMed]
[32] Lu, Z., Zhu, L., Yi, C., Su, B. and Wang, R. (2025) C5a/C5aR Regulates Th1/Th2 Imbalance in Sepsis-Associated Lung Injury by Promoting Neutrophil Activation to Increase PAD4 Expression. Annals of Medicine, 57, Article ID: 2447406. [Google Scholar] [CrossRef] [PubMed]
[33] Padovani, C.M. and Yin, K. (2024) Immunosuppression in Sepsis: Biomarkers and Specialized Pro-Resolving Mediators. Biomedicines, 12, Article No. 175. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, S., Wu, Z., Chang, W., Liu, F., Xie, J., Yang, Y., et al. (2020) Classification of Patients with Sepsis According to Immune Cell Characteristics: A Bioinformatic Analysis of Two Cohort Studies. Frontiers in Medicine, 7, Article ID: 598652. [Google Scholar] [CrossRef] [PubMed]
[35] Zhu, X., Lu, Q., Liu, X. and Zeng, X. (2025) Predictive Models of Immune Microenvironment-Related Markers in Patients with Sepsis Accompanied by Myocardial Dysfunction and Their Roles in Diagnosis. Frontiers in Cardiovascular Medicine, 12, Article ID: 1705594. [Google Scholar] [CrossRef